Research funding across the UK
Our interactive map shows the cities and institutions where we are directly funding research.
Research funding across the UK
From Edinburgh to Cardiff, Belfast to London, we're supporting research projects but also strategic investments including the Centres of Research Excellence, Centres of Regenerative Medicine, the BHF Data Science Centre and Accelerator Awards. Use the interactive visualisations below to explore where we fund research projects in the UK.
Through our commitment to beating heartbreak from all heart and circulatory diseases and their risk factors, we currently support over £430m of lifesaving research across 47 institutions in the UK to better understand, prevent, and treat heart and circulatory diseases.
The map on this page shows the cities and institutions where we are directly funding research.
Our maps are best viewed on desktop screens or larger mobile devices.
Funding across the UK
Strategic research investments
Our interactive map shows funding of research centres and 4-year PhD programmes across UK universities.
Our research workforce
Our interactive map shows the work of over 1,200 research staff across the UK, including salaried research staff on BHF awards or personal awards for early career scientists through to BHF Professors.
Funding by condition
Funding by condition
Our interactive visual map shows some of the £430m of research projects across 47 institutions in the UK to better understand, prevent and treat heart and circulatory diseases.
Latest investment by condition
In the 2023/24 financial year we awarded around £112m of research grants to better understand, prevent and treat heart and circulatory diseases.
Funding in clinical trials
Clinical trials by type of research
We are currently supporting 46 clinical trials worth around £40m. They provide crucial evidence that diagnostic tests or treatments are safe and effective.
Clinical trials by condition
Clinical trial provide crucial evidence that diagnostic tests or treatments are safe and effective. We fund clinical trials across a broad range of heart and circulatory conditions and their risk factors, such as diabetes and chronic kidney disease.